CTRI/2021/04/033243尚未招募3 期
Clinical Study To Evaluate The Efficacy And Safety Of Psorlyn Tablet And Psorlyn Oil In Psoriasis W.S.R. Kitibha
DrVasishths Ayuremedies0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Children age group between 10 ââ?¬â?? 16 years of either sex.
- •2. Children having classical sign and symptom and diagnosed as psoriasis.
- •3. Patient should be capable of obeying the instruction related to course of therapy.
排除标准
- •1. Patient with k/c/o any chronic systemic illness and allergic disorders.
- •2. Patient with k/c/o any other chronic skin disorder except psoriasis.
- •3. Patient not fulfilling the inclusion criteria.
- •4. Patient/Attendant not willing to give written consent for participation in the research study.
研究者
相似试验
招募中
1 期
Evaluate The Efficacy And Safety Of HMTG-122106 In ChildreCTRI/2023/07/054858Himalaya Wellness Company
尚未招募
1 期
To Evaluate The Efficacy And Safety Of HSGM-122104 Inchildren in (Healthy Human Volunteers)CTRI/2023/07/054999Himalaya Wellness Company
已完成
2 期
TO Find the Effect of LION�S MANE CAPSULE as Nutritional SupplementCTRI/2022/03/040725DXN Manufacturing India Pvt Ltd24
进行中（未招募）
不适用
Clinical Study to Evaluate the Efficacy and Safety of the Combination Therapy Candesartan Cilexetil 32 mg plus Hydrochlorothiazide 25 mg in Patients with Severe HypertensioSubjects with severe essential hypertension (SBP between 150 mmHg and 200 mmHg AND DBP between 110 mmHg and 120 mmHg) who did not receive any antihypertensive treatment before will be included in the studyMedDRA version: 9.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2009-011776-30-DETakeda Pharma GmbH100
已完成
2 期
TO Find the Effect of Codyceps Tablet as Nutritional SupplementCTRI/2022/03/040784DXN Manufacturing India Pvt Ltd24